Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Hueb, Whady ^a,c   Gersh, Bernard J ^b   Rezende, Paulo C ^a   Garzillo, Cibele L ^a   Lima, Eduardo G ^a   Vieira, Ricardo D ^a   Garcia, Rosa Maria R ^a   Favarato, Desiderio ^a   Segre, Carlos Alexandre W ^a   Pereira, Alexandre C ^a   Soares, Paulo R ^a   Ribeiro, Expedito ^a   Lemos, Pedro ^a   Perin, Marco A ^a   Strunz, Célia C ^a   Dallan, Luis A O ^a   Jatene, Fabio B ^a   Stolf, Noedir A G ^a   Hueb, Alexandre C ^a   Dias, Ricardo ^a   Gaiotto, Fabio A ^a   da Costa, Leandro Menezes A ^a   Oikawa, Fernando Teiichi C ^a   de Melo, Rodrigo Morel V ^a   Serrano Junior, Carlos V ^a   de Ávila, Luiz Francisco R ^a   Villa, Alexandre V ^a   Filho, José Rodrigues P ^a   Nomura, César ^a   Ramires, José A F ^a   Filho, Roberto K ^a   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MAYO CLINIC   (United States)

^c NONE   (Brazil)

Author keywords

CABG; Cardiopulmonary bypass; Myocardial infarction; Necrosis markers; PCI

Indexed keywords

CREATINE KINASE MB; GADOTERATE MEGLUMINE; TROPONIN I;

ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MAGNETIC RESONANCE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS;

EID: 84864941905     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-65     Document Type: Article

References (8)

1. Thygesen K. Alpert JS. White HD: Universal definition of myocardial infarction. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J 2007, 28:2525-2538.
2. Porto I, Selvanayagam JB, Van Gaal WJ, Prati F, Cheng A, Channon K, Neubauer S, Banning AP. Plaque volume and occurrence and location of peri procedural myocardial necrosis after percutaneous coronary intervention: insights from delayed enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 2006, 114:662-669. 10.1161/CIRCULATIONAHA.105.593210, 16894040.
3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121(7):e46-e215.
4. Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, Lansky AJ, Mehran R, Stone GW. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2009, 54:477-486. 10.1016/j.jacc.2009.03.063, 19628125.
5. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 2011, 364:453-464. 10.1056/NEJMra0912134, 21288097.
6. Pegg TJ, Selvanayagam JB, Francis JM, Karamitsos TD, Maunsell Z, Yu LM, Neubauer S, Taggart DP. A randomized trial of on-pump beating heart and conventional cardioplegic arrest in coronary artery bypass surgery patients with impaired left ventricular function using cardiac magnetic resonance imaging and biochemical markers. Circulation 2008, 118:2130-2138. 10.1161/CIRCULATIONAHA.108.785105, 18981306.
7. Pegg TJ, Maunsell Z, Karamitsos TD, Taylor RP, James T, Francis JM, Taggart DP, White H, Neubauer S, Selvanayagam JB. Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI. Heart 2011, 97:810-816. 10.1136/hrt.2010.213462, 21378388.
8. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 2005, 7(5):775-782. 10.1080/10976640500295516, 16353438.